Latest news from Fool.com - Headlines feed

Latest news from Fool.com - Headlines feed

  1. Here's Why Halozyme Therapeutics, Inc Is Falling

    03.30 / 15:59 fool.com Fool.com - Headlines
    Shares drop after the company announced that enrollment in a phase 1b/2 trial pancreatic cancer has been…
  2. 3 Top Smartwatches Stocks to Buy in 2017

    03.30 / 15:59 fool.com Fool.com - Headlines
    Apple, Samsung, and Garmin are leading the pack in smartwatch sales heading into this year -- and each could be a longtime winner in this…
  3. 3 IRA Rules to Live By

    03.30 / 15:59 fool.com Fool.com - Headlines
    Once you've got these three critical IRA rules under your belt, you'll be ready to make the most of the powerful retirement account and improve your future financial…
  4. Better Buy: Helmerich & Payne, Inc. vs. Noble Energy, Inc.

    03.30 / 15:59 fool.com Fool.com - Headlines
    As U.S. oil drilling activity picks up, which is the better energy play... Helmerich & Payne or Noble…
  5. Sirius XM Will Get the Last Laugh on Pandora

    03.30 / 15:59 fool.com Fool.com - Headlines
    Some Pandora board members are reportedly still interested in a sale, but it may already be too late to come out on…
  6. Could This Be an Overlooked Opportunity for Las Vegas Investors?

    03.30 / 14:53 fool.com Fool.com - Headlines
    One of the newest publicly traded casino companies just reached its one-year anniversary. This could be a new opportunity for gambling investors, but it's still…
  7. Has Gilead Sciences Lost Its Way?

    03.30 / 14:53 fool.com Fool.com - Headlines
    John Milligan's first year as Gilead's CEO hasn't been kind to…
  8. Clash of the Food Service Distribution Titans

    03.30 / 14:53 fool.com Fool.com - Headlines
    Food service giants Sysco and US Foods record annual revenue of $77 billion between them. We tackle the market’s view of their sales and associated p…
  9. Dave & Buster’s Continues to Buck the Trend

    03.30 / 14:53 fool.com Fool.com - Headlines
    While the company's offerings continue to gain traction, it's also attracting…
  10. 1 Key Metric for Silver Wheaton Corp. Investors to Focus On

    03.30 / 14:53 fool.com Fool.com - Headlines
    Big deals made the last few years exciting for gold and silver streaming company Silver Wheaton. Now it's time to watch organic…
  11. Better Buy: Goldcorp Inc. vs. Yamana Gold

    03.30 / 13:46 fool.com Fool.com - Headlines
    What's next for gold miners Goldcorp and Yamana Gold is the big question, and one has more in the works than the…
  12. The 2 Most Dangerous Types of Dividend Stocks

    03.30 / 13:46 fool.com Fool.com - Headlines
    High-yielding stocks with struggling business and debt-funded payouts are often bad news for income…
  13. How Much Pain Will Congress Inflict on These Opioid Drugmakers' Stocks?

    03.30 / 13:46 fool.com Fool.com - Headlines
    A Senate committee targets opioid drugmakers Purdue, Johnson & Johnson, Insys, Mylan, and…
  14. The Ultimate Kick in the Pants: Valeant's Former CEO Is Suing the Company

    03.30 / 13:46 fool.com Fool.com - Headlines
    No joke: Valeant's former CEO is looking to collect almost 2.5 million shares in performance-based…
  15. 3 Top Energy Stocks to Buy Now

    03.30 / 13:46 fool.com Fool.com - Headlines
    TransCanada, Devon Energy, and National Oilwell Varco are great energy stocks to own for the long…
  16. The Hawaiian Airlines Pilot Contract Saga Is Over: Investors Should Be Glad

    03.30 / 12:40 fool.com Fool.com - Headlines
    Labor peace is returning to Hawaiian Airlines, at a cost that the company clearly can…
  17. Better Buy: Goldcorp Inc. vs. IAMGOLD Corp.

    03.30 / 12:40 fool.com Fool.com - Headlines
    The promise of a bright future suggests that this miner offers investors a golden…
  18. 3 Credit Cards for People Who Want Cheap Travel Deals

    03.30 / 12:40 fool.com Fool.com - Headlines
    If you're great at finding travel deals on your own, these three travel credit cards can complement your shopping…
  19. Regeneron's Game-Changing New Eczema Drug Could Be a Blockbuster

    03.30 / 12:40 fool.com Fool.com - Headlines
    The FDA has approved Dupixent for moderate to severe eczema, making it the first non-topical drug to win regulatory support in the…
  20. Major Players and Trends to Watch in the World of Video Games

    03.30 / 12:40 fool.com Fool.com - Headlines
    With two billion gamers worldwide and major advancements in technology, the video game industry offers plenty of opportunities for…